| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 96.94M | 113.06M | 132.50M | 86.61M | 82.72M | 69.46M |
| Gross Profit | 12.33M | 14.72M | 54.31M | 8.94M | 4.17M | 3.58M |
| EBITDA | 10.44M | 13.23M | 15.69M | 7.97M | 2.16M | 3.62M |
| Net Income | 6.07M | 8.27M | 10.32M | 4.73M | 68.00K | 1.37M |
Balance Sheet | ||||||
| Total Assets | 75.31M | 78.11M | 81.60M | 60.68M | 52.95M | 49.56M |
| Cash, Cash Equivalents and Short-Term Investments | 18.73M | 21.70M | 22.08M | 11.63M | 10.38M | 15.13M |
| Total Debt | 1.63M | 1.64M | 1.80M | 2.69M | 1.00M | 1.26M |
| Total Liabilities | 24.06M | 25.09M | 33.76M | 26.33M | 23.56M | 20.34M |
| Stockholders Equity | 51.25M | 53.02M | 47.84M | 34.35M | 29.39M | 29.22M |
Cash Flow | ||||||
| Free Cash Flow | -39.00K | 3.63M | 13.05M | 2.00M | -4.26M | -2.67M |
| Operating Cash Flow | 5.12M | 8.63M | 15.95M | 6.51M | -1.91M | -451.00K |
| Investing Cash Flow | -3.95M | -4.67M | -2.63M | -4.57M | -2.06M | -1.92M |
| Financing Cash Flow | -4.31M | -4.42M | -2.87M | -687.00K | -774.00K | -357.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £1.18B | 8.74 | 24.69% | 3.08% | -1.17% | 12.31% | |
70 Neutral | £48.71M | 8.05 | 11.79% | 7.35% | -25.56% | -42.49% | |
68 Neutral | £51.44M | 10.14 | 3.98% | 2.45% | 5.54% | 209.72% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £47.14M | 32.87 | 23.37% | 3.37% | 11.70% | 79.80% | |
57 Neutral | £40.03M | 21.51 | 5.90% | 3.29% | -6.46% | -56.20% | |
48 Neutral | £10.62M | -3.33 | -10.69% | 2.47% | -3.17% | 69.15% |
Billington Holdings Plc announced that Gutenga Investments PCC Limited has transferred its entire shareholding of 2,586,866 ordinary shares to Gutenga Stiftung Lichtenstein Foundation. This transaction, which involves a significant 19.4% of the company’s total issued shares, highlights the internal restructuring of share ownership linked to Dr. Alexander Ospelt, a director at Billington and a member of the Foundation Council of Gutenga Stiftung Lichtenstein Foundation. This move could have implications for the company’s governance and stakeholder dynamics.
The most recent analyst rating on (GB:BILN) stock is a Hold with a £333.00 price target. To see the full list of analyst forecasts on Billington Holdings stock, see the GB:BILN Stock Forecast page.